Literature DB >> 14757495

The potential of nasal application for delivery to the central brain-a microdialysis study of fluorescein in rats.

Morten Aavad Bagger1, Erik Bechgaard.   

Abstract

Previous animal studies have shown that various types of nasally administered drugs and model substances can access the central nervous system (CNS) via direct transport across the olfactory epithelium, and thereby circumventing the blood-brain barrier (BBB). These compounds, however, have mainly been identified in the cerebrospinal fluid and the olfactory bulbs which are usually not pharmacologically relevant targets. The aim of the present study was to evaluate the potential of targeting the central brain by olfactory absorption by use of sodium fluorescein as a hydrophilic model substance with limited permeability across the blood-brain barrier. Microdialysis probes were implanted in blood and in right and left side of the brain (striatum) in rats. The pharmacokinetics of sodium fluorescein was studied from 0 to 180min following intravenous and unilateral nasal administration without occlusion of the oesophagus. Pharmacokinetic modelling showed a significantly higher absorption rate and lower T(max) in the ipsilateral striatum (0.097min(-1) and 41min) compared with the contralateral side (0.056min(-1) and 54min). The rate of elimination in brain was significantly lower after nasal administration (0.004min(-1)) compared with intravenous administration (0.012min(-1)). However, the brain to plasma area under the curve ratios of model substance were low (2-3%) and not significantly different between right and left side of the brain, regardless of the route of administration. The results obtained by microdialysis were supported by findings in whole brain homogenates where concentrations of fluorescein were approximately 40% higher in the right striatum compared with the left side initially after nasal administration to the right nostril of rats. Despite some indications of olfactory transport to the central rat brain it was concluded that the drug targeting potential of sodium fluorescein and most likely other hydrophilic compounds is limited.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14757495     DOI: 10.1016/j.ejps.2003.10.012

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  7 in total

1.  Intranasal pyrrolidine dithiocarbamate decreases brain inflammatory mediators and provides neuroprotection after brain hypoxia-ischemia in neonatal rats.

Authors:  Zhi Wang; Huijuan Zhao; Shuling Peng; Zhiyi Zuo
Journal:  Exp Neurol       Date:  2013-08-29       Impact factor: 5.330

2.  Structural variation governs substrate specificity for organic anion transporter (OAT) homologs. Potential remote sensing by OAT family members.

Authors:  Gregory Kaler; David M Truong; Akash Khandelwal; Megha Nagle; Satish A Eraly; Peter W Swaan; Sanjay K Nigam
Journal:  J Biol Chem       Date:  2007-06-05       Impact factor: 5.157

3.  Demonstration of Direct Nose-to-Brain Transport of Unbound HIV-1 Replication Inhibitor DB213 Via Intranasal Administration by Pharmacokinetic Modeling.

Authors:  Qianwen Wang; Yufeng Zhang; Chun-Ho Wong; H Y Edwin Chan; Zhong Zuo
Journal:  AAPS J       Date:  2017-12-27       Impact factor: 4.009

4.  Subacute intranasal administration of tissue plasminogen activator increases functional recovery and axonal remodeling after stroke in rats.

Authors:  Zhongwu Liu; Yi Li; Li Zhang; Hongqi Xin; Yisheng Cui; Leah R Hanson; William H Frey; Michael Chopp
Journal:  Neurobiol Dis       Date:  2011-11-15       Impact factor: 5.996

Review 5.  The post-cardiac arrest syndrome: A case for lung-brain coupling and opportunities for neuroprotection.

Authors:  Nguyen Mai; Kathleen Miller-Rhodes; Sara Knowlden; Marc W Halterman
Journal:  J Cereb Blood Flow Metab       Date:  2019-03-13       Impact factor: 6.200

6.  Permeabilization of the blood-brain barrier via mucosal engrafting: implications for drug delivery to the brain.

Authors:  Benjamin S Bleier; Richie E Kohman; Rachel E Feldman; Shreshtha Ramanlal; Xue Han
Journal:  PLoS One       Date:  2013-04-24       Impact factor: 3.240

7.  Comparative pharmacokinetics of tetramethylpyrazine phosphate in rat plasma and extracellular fluid of brain after intranasal, intragastric and intravenous administration.

Authors:  Dongmei Meng; Haoyang Lu; Shanshan Huang; Minyan Wei; Pingtian Ding; Xianglin Xiao; Yuehong Xu; Chuanbin Wu
Journal:  Acta Pharm Sin B       Date:  2014-01-24       Impact factor: 11.413

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.